GenUs BioSystems Launches Gene Expression Profiling Service for Picogram Quantities of Total RNA; Microarray services for laser-captured and FACS-sorted cells
GenUs BioSystems, a state-of-the-art bioarray service laboratory, announced the launch of its gene expression profiling service for picogram quantities of RNA. The company offers the service to researchers who have as few as 10 cells or 100 picograms of total RNA.
This service provides valuable genomic data to researchers with very limited sample amounts. Scientists often use techniques such as Laser Capture Microdissection (LCM) or fluorescence-activated cell sorting (FACS) to collect specific cells from biological tissue. Often, such small amounts of RNA are insufficient to achieve accurate bioarray results. With the launch of Genus BioSystems’ additional service, researchers with limited starting material now have the opportunity to easily acquire valuable genomic data.
“Gene expression data is an extremely useful resource to help point research programs in the right direction, but researchers who work with small sample amounts have had difficulty generating enough RNA to produce the results they need,” said Dr. Scott Magnuson, president of GenUs BioSystems. “Our new gene expression profiling service for picogram quantities of RNA is another way we help bring the power of genomics to all scientists.”
Consistent with its philosophy of using only what the company believes are the best available technologies, GenUs BioSystems uses the Arcturus RiboAmp(TM) RNA Amplification Kit to generate enough RNA to run bioarray experiments on Amersham/G.E. Healthcare CodeLink(TM) bioarrays.
GenUs BioSystems’ gene expression profiling service for picogram quantities is the latest addition to the company’s portfolio of genomics services, which includes experiment design consulting, RNA isolation, gene expression profiling, data analysis, and data consulting.
“Although scientists understand the value of genomic data, they are often reluctant to invest in the equipment, staff, and training needed to run bioarray experiments. By outsourcing their gene expression experiments to our full-service laboratory, researchers can obtain easily-interpreted, accurate, and reproducible genomic data – allowing them to see “the big picture”, and quickly focus on their genes of interest,” said Dr. Magnuson.
About GenUs BioSystems: GenUs BioSystems, Inc. is a service laboratory committed to using state-of-the-art techniques to conduct genomic experiments using bioarray technology in the emerging field of systems biology. Applications include genomic research, diagnostics, drug discovery, drug efficacy and toxicity studies, and pharmocogenetics. GenUs BioSystems provides a time-saving and cost-effective alternative to performing technically challenging bioarray experiments in-house. For more information, visit www.genusbiosystems.com .
